License for use of iBodies® to measure free testosterone in blood bought by Immunotech, a member of the Beckman Coulter group!
11.8.2020The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague), the Institute of Macromolecular Chemistry of the Czech Academy of Sciences (IMC), and Charles University…
Czech anti-covid19 #hackathon won by two i&i Prague accelerated projects
25.6.2020Virtual #hackathon was a national challenge for all Czech scientists, companies, students and science-enthusiasts with a simple goal: gather the best Czech bio-technologies to fight COVID-19 crisis.
iBodies established cooperation with Ximbio, a TTO within the UK’s largest charity, Cancer Research UK
22.6.2020Project iBodies, supported by IOCB Tech and i&i Prague, is focused on developing novel macromolecules designed to fully substitute antibodies in common biochemical methods. Recently, iBodies established a cooperation…
Enantis – first biotechnology spin-off from Masaryk University in Brno
12.5.2020Enantis s.r.o. was founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno, Czech Republic. Project went through long development and its expertise is now based…
Prague startup RIOCATH had recently entered market with its world-unique catheter!
12.5.2020RIOCATH Global, a company established in collaboration with IOCB Tech, has developed a revolutionary type of catheter based on world-unique technology applicable for all tubular medical devices. Since its birth…
LAM-X – light-activated nanomaterials for face-masks and respirators
12.5.2020LAM-X a.s. is the newest company established in cooperation with i&i Prague. It develops light-activated nanomaterials which provide protection from bacteria, viruses and other pathogens. The lead product is a…
iBodies – synthetic antibodies from IOCB
12.5.2020iBodies is a project originated at IMC, IOCB and Charles University, which is currently under a pre-seed incubation. The iBodies team focuses on development of the novel…
Elphogene: non-invasive screening of patients in advanced stages of cancer
12.5.2020Elphogene s.r.o. is a Czech spin-off company that succeeds decades of intensive research performed at Genomac research centre as well as thanks to collaborations with leading oncology centres. Using their…
DIANA Biotechnologies – technology that raised EUR 3M in 3 years
12.5.2020DIANA Biotechnologies started as a project of a PhD. student at IOCB. After less than 3 years of pre-seed incubation it developed into an independent biotech company, with their own…
DRACEN Pharmaceuticals – Novel glutamine antagonist as anticancer therapies
12.5.2020One of the first project i&i Prague participated in is Dracen Pharmaceuticals. Dracen itself started as an international science team at the Institute of Organic Chemistry and Biochemistry (IOCB Prague)…